Background: Pancreatic islet transplantation is currently proven as a promising treat-
group). To confirm IL-6 blocking effect, C-reactive protein (CRP) levels and serum IL-6 concentration were measured. Scheduled biopsy of the margin of the posterior segment right lobe inferior of the liver was performed at 3 weeks after transplantation to assess the degree of revascularization of the transplanted islets. Immunohistochemical staining using anti-insulin, anti-CD31 antibodies, and lectin IB4 was conducted to find the origin of endothelial cells in the islet graft.
Results: CRP significantly increased at 1~2 days after transplantation in Basal group, but not in Tocilizumab group, and higher serum IL-6 concentration was measured in latter group, showing the biological potency of tocilizumab. In Basal group, welldeveloped endothelial cells were observed on the peri-and intraislet area, whereas the number of CD31 + cells in the intraislet space was significantly reduced in Tocilizumab group. Finally, new endothelial cells in the pig islet graft were positive for CD31, but not for lectin IB4, suggesting that they are originated from the recipient monkey.
| INTRODUCTION
Pancreatic islet transplantation is currently proven as a promising treatment for type 1 diabetes patients with labile glycemia and severe hypoglycemic unawareness. Pancreatic islets are highly vascularized cells within the pancreas, and this vasculature is required for functional insulin release and physiological blood glucose control.
1,2
However, during islet isolation, vascular connection between the islet and the surrounding tissues can be severed, and revascularization process is required for survival, function, and successful engraftment of the islets upon transplantation. [3] [4] [5] Although both donor and recipient endothelial cells contributed new vasculature after engraftment in islet allotransplantation setting, 6, 7 it is unknown whether porcine endothelial cells in the isolated pig islets have a similar contributing role in new vessel generation.
The revascularization process for re-establishment of the blood supply to the transplanted islets has been demonstrated to occur within several days and are susceptible to hypoxic conditions until revascularization is complete. 4, 8, 9 Also, during this period, several pro-inflammatory cytokines such as IL-1β, TNF-α, and IL-6 were secreted from both donor islets and recipient cells, and they can damage transplanted islets, resulting in reduction of the engrafted islet mass.
10-12
IL-6 is a pleiotropic factor, having good and bad impacts on many physiological processes. [13] [14] [15] For example, IL-6 has been shown to increase vascular endothelial growth factor and induce angiogenesis in a tumor model 16 and stimulate circulating blood-derived endothelial progenitor cell during angiogenesis in vitro. 17 In contrast, IL-6 has been reported to amplify activation of coagulation through up-regulation of tissue factor on innate immune cells and resulted in systemic inflammation in xenograft recipient (SIXR). 18, 19 Therefore, it is intriguing to test whether blockade of IL-6 signaling upon islet xenotransplantation can lead to beneficial or deleterious effect on revascularization of the transplanted islet and final clinical outcome. Therefore, in this study,
we investigated the effect of IL-6 receptor antagonist, tocilizumab, on revascularization of the transplanted islets in pig to NHP islet xenotransplantation model using anti-CD40 antibody and tacrolimusbased immunosuppression regimen. Also, we examined whether the newly formed blood vessels in the pancreatic islets in the liver were from donor or recipient origin after islet xenotransplantation.
| MATERIALS AND METHODS

| Animals
Five rhesus monkeys (Macaca mulatta) were used in this study. 
| Islet transplantation and immunosuppression
Islets were isolated from designated pathogen-free (DPF) Seoul National University (SNU) miniature pigs. Isolated islets were trans- 
Conclusions:
Our results demonstrated that tocilizumab can delay revascularization of the transplanted islet, although this effect had no significant correlation to the overall islet graft survival. In the pig to NHP islet xenotransplantation model, the endothelial cells from recipient monkey form new blood vessels in and around pig islets.
K E Y W O R D S
IL 6 receptor antagonist, islet xenotransplantation, revascularization, tocilizumab and tacrolimus. In tocilizumab-treated group, three monkeys were treated with basal immunosuppression and tocilizumab as an IL-6 receptor antagonist.
| Biopsy and immunohistochemistry
Porcine pancreas, isolated pancreatic islets, and transplanted liver tissue were used for histological experiments. After total pancreatectomy, the margin of the connecting lobe (10 mm) was taken for a sample. Isolated islets were cultured for 1 day or 7 days after isolation, and pre-embedding was performed using fibrin gel area were counted. They were discriminated between inner region of islet and 30 μm outer region of the islets. Number of islets analyzed was over 10 slides using different area (at least 100 μm interval from previous section) ( Figure S1 ).
| C-reactive protein (CRP) measurement
The CRP level was measured with a latex-enhanced turbidimetric immunoassay (Denka Seiken, Tokyo, Japan) using an automated analyzer (Toshiba 200FR; Toshiba, Tokyo, Japan). The detection limit of this assay is 0.1 mg/L. Both intra-and interassay coefficients of variation were < 10%.
| Cytokine beads array (CBA)
The cytometric bead array assay was performed to measure peripheral blood IL-6 concentration according to the instructions provided by the manufacturer (BD Biosciences, San Jose CA).
| Statistical analysis
The statistical software GRAPHPAD PRISM5 (GraphPad Software, Inc., La Jolla, CA) was used for one-way ANOVA test. Data with P values less than .05 were considered to be statistically significant.
| RESULTS
| Islet transplantation
Five STZ-induced diabetic monkeys were transplanted with ~100 000 IEQ/kg (80 645~100 000, mean 93 575 IEQ/kg) adult pig islets isolated from SNU miniature pigs and divided into two groups depending on immunosuppression regimen ( a Graft survival day; this was defined as the day on which the serum porcine C-peptide fell <0.15 ng/mL, as measured by ELISA.
was treated with ATG, anti-CD40 antibody, sirolimus, and tacrolimus (Basal group), and the other group was additionally given IL-6 receptor antagonist, tocilizumab (Tocilizumab group), on top of the basal immunosuppression. All recipients restored normoglycemia shortly after transplantation and controlled blood glucose levels for variable periods. During the normoglycemic period with or without exogenous insulin treatment, porcine C-peptide was detected in serum ( Figure 1 ).
| The effect of tocilizumab
Tocilizumab was additionally given in Tocilizumab group compared with Basal group. To test whether tocilizumab has been working in vivo, two independent assays were performed. First, C-reactive protein (CRP) which is promptly induced by IL-6 in the liver was measured. Basal CRP level at pre-transplantation was measured below 0.5 mg/dL in the most cases except R131. However, CRP significantly increased at days F I G U R E 1 Blood glucose control by the transplanted pig islets using anti-CD40 mAb + tacrolimus-based (Basal group) and anti-CD40 mAb + tacrolimus + tocilizumab-based immunosuppression (Tocilizumab group). Fasting blood glucose levels and porcine and monkey C-peptide were measured in five monkeys that were intraportally transplanted with adult pig islets. In Basal group, R008 and R131 monkeys were insulinindependent for 14 and 3 days, respectively (A) In Tocilizumab group, R143, R144, and R147 monkeys were insulin-independent for 134, 11, and 3 days, respectively (B) Fasting blood glucose (gray line), porcine C-peptide (red bar), monkey C-peptide (▼), and exogenous insulin (pink bar) are indicated. The data of R008 and R131 were previously reported in Xenotransplantation (2017, doi: 10.1111/xen.12356) 1 and 2 after transplantation in Basal group, but not in Tocilizumab group (Figure 2A) . Second, the cytometric bead array (CBA) assay was performed to measure IL-6 concentration in blood serum. Basal group showed low levels of IL-6 in peripheral blood such that only 27 pg/mL was measured at 4 hrs after transplantation and followed by returning to basal levels. In contrast, IL-6 levels reached to minimum 97 pg/ mL and maximum 471 pg/mL, which levels are about 6-fold to 20-fold higher than Basal group ( Figure 2B ). When these values are indicated as area under the curve (AUC) from 0 to 5 days after transplantation, AUC values of Basal group were 36.1 to 43.61, whereas Tocilizumab group was 195.8 to 871.5 ( Figure 2C ). Because free form of IL-6 is accumulated in the presence of IL-6 receptor antagonist, tocilizumab, these results showed that tocilizumab is effective for preventing CRP from increase and IL-6 from delivering a signal through IL-6 receptor.
| CD31 (PECAM) distribution after islet transplantation
To examine the effect of tocilizumab on revascularization of the transplanted pig islets, scheduled biopsy was performed at 3 weeks after transplantation (20 or 21 days) in both groups. Subsequent immunohistochemical staining showed that the transplanted pig islets and endothelial cells are positively stained with insulin and CD31
antibodies, respectively, in the liver of the recipient monkeys. In
Basal group, the size of the transplanted islets engrafted in the liver parenchyma ranged 100 to 200 μm in diameter. CD31 + endothelial cells were observed both on the peripheral and intraislet areas, suggesting near total revascularization. In contrast, in Tocilizumab group, the size of the islets was 100 to 150 μm in diameter, and intensity of insulin-positive beta cells and the extent of CD31 + cell distribution in the intraislet spaces were significantly lower ( Figure 3 ).
To substantiate this finding in more objective manner, the number of CD31 positive cells either in peri-or intraislet area and total β-cells were counted (Figure 4 ). Collectively, these data confirmed that tocilizumab had negative effect on revascularization of the transplanted islets, delaying endothelial cell ingrowth into the islets.
F I G U R E 2 C-reactive protein (CRP) levels and IL-6 concentration after pig to monkey islet xenotransplantation. (A) Graph showing the CRP levels. CRP significantly increased at 1~2 days in R008 and R131 monkeys after transplantation, whereas the levels remained lower in R143, R144, and R147 monkeys. (B) The concentration of IL-6 in peripheral blood. In Tocilizumab group, IL-6 levels measured at 4 hrs after transplantation are 6-fold to 20-fold higher than in control group. (C) The serum IL-6 level from day 0 to day 5 after transplantation is presented as area under the curve (AUC)
| Endothelial cells origin in the islet grafts
To determine the origin of endothelial cells in the pig islet grafts, alpha
Gal and CD31 staining were performed. First, IB4-Lectin, which is specific for alpha Gal moiety, was used to detect pig endothelial cells in donor pig pancreas and isolated islet of the SNU miniature pig. As seen in Figure 5 , lectin IB4 distributed throughout the pancreas including islets and exocrine tissues. Of note, lectin IB4 was found in endothelial cells in intraislet area. In case of isolated islet, the lectin distributed in the 1-day-cultured islet similar to in the donor pancreas, but the number of lectin IB4 + cells decreased and the remaining cells were morphologically distinct (rather shrunk) after 7 days of culture.
In contrast, IB4 lectin was not detected in the transplanted islets as well as in the liver of the recipient, suggesting that donor pig endothelial cells die out from the islets. Finally, immunohistochemical staining using anti-human CD31 (JC70A) antibody, which has been reported F I G U R E 3 Insulin and CD31 distribution in the islets transplanted to the liver of recipient monkeys. Liver samples taken at 20 or 21 days after pig islet transplantation were immunostained with anti-insulin and anti-CD31 antibodies. Results show well-engrafted islet β-cells (red) and lining of CD31 + endothelial cells (blue). In Basal group treated with basal immunosuppression, the transplanted islets had well-developed CD31 + cells, and these endothelial cells were observed on the peripheral and intraislet areas. By contrast, in Tocilizumab group, intensity of insulin in β-cells and the extent of CD31 + cells in the intraislet area were significantly lower than in Basal group F I G U R E 4 Histological semiquantitative analysis of CD31 + cells in pig islet in monkey liver. Semiquantitative histological analyses of ratio of CD31 + cells either peri-or intraislet area to total β-cell numbers were conducted. Basal group shows well-developed endothelial cells of the transplanted islets, while in Tocilizumab group, the extent of distribution of CD31 + cells was significantly reduced (*P < .05) not to react with porcine tissue, was used for donor pig pancreas, isolated pig islet, and liver biopsy sample. Indeed, this antibody did not bind to porcine endothelial cells, but detected endothelial cells in both pig islet graft and recipient liver. Taken together, this result clearly demonstrated that the origin of endothelial cell in the pig islet grafts was the recipient, but not the donor.
| DISCUSSION
In the present study, we have shown that IL-6 receptor (R) antagonist, tocilizumab, had negative effect on revascularization of the transplanted pig islets, delaying endothelial cells ingrowth into the islets and the endothelial cells in the islet grafts entirely came from the recipient in pig to NHP islet xenotransplantation model.
IL-6 is a soluble mediator that has both roles as a pro-inflammatory cytokine and an anti-inflammatory cytokine, including various biological effects on inflammation, immune response, and hematopoiesis.
22
Tocilizumab has been known to inhibit IL-6R-mediated signaling which is involved in the elevation of serum IL-6 levels and the reduction Creactive protein (CRP) levels. 23, 24 Recently, it has been reported that IL-6R antagonist has a beneficial effect on artery patch and kidney xenotransplantation model by reducing the inflammatory response.
25,26
In this study, IL-6R blockade using Tocilizumab was incorporated to reduce initial inflammation during early period after islet transplantation. Indeed, CRP as an indicator of inflammation was decreased in tocilizumab-treated group. On the other hand, we found that revascularization of the transplanted islet was significantly inhibited by a IL-6R blockade using semiquantitative histochemical analyses. Therefore, the beneficial effect of IL-6R blockade would be negated by harmful F I G U R E 5 Insulin, Lectin IB4, and CD31 distribution in pig pancreas, isolated islet, and transplanted islet in the recipient monkey liver. In donor pancreas of the SNU miniature pig, Lectin IB4 distributed throughout the pancreas including islets and exocrine tissues. IB4 lectin was detected in endothelial cells in the intraislet area. In the isolated islet, IB4 lectin was detected 1 day after isolation. However, IB4 lectin was significantly reduced in the 7-day-cultured islets after isolation. IB4 Lectin was not found in the transplanted islets as well as in the recipient liver. Human-specific CD31 + cells distributed throughout the recipient liver including transplanted islets, but not in donor pancreas effect on revascularization of the transplanted islets. Consistent with this notion, overall graft survival was not improved by IL-6R blockade.
Islet isolation is an essential procedure for islet transplantation.
However, as the isolated islets are completely devascularized because of enzyme digestion during isolation, they are exposed to prolonged ischemia and limited supply of oxygen and nutrients, leading to cell death including apoptosis and/or necrosis, eventually early graft failure. [27] [28] [29] [30] Thus, revascularization process is necessary for successful islet graft function upon transplantation. Previous report suggested that this process requires several days to 2 weeks if there are no facilitating treatments. 3,30,31 Therefore, we examined the effect of tocilizumab on revascularization process of the islets transplanted intraportally into liver at 20 days after transplantation.
As IL-6 has been reported to facilitate neovascularization in various models and be essential for liver regeneration, we anticipated that blocking of IL-6 signaling would be detrimental to islet revascularization.
Indeed, Tocilizumab group showed significantly reduced number of endothelial cells in the intraislet area. One report showed that the intraislet endothelial cells play a key role in the process of revascularization.
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Interestingly, although Tocilizumab group showed that revascularization was not complete in intraislet areas, blood glucose levels were still well controlled by porcine insulin from the transplanted islets. It is likely that transplanted islets would sense blood glucose level and secrete insulin extracellularly and this in turn flow into sinusoid for systemic circulation, even though this mechanism is obviously less efficient as previously suggested. [32] [33] [34] These studies reported that transplanted islets are dependent on diffusion of nutrients and oxygen from the surrounding tissues and reduction of islet vasculature in the immediate post-transplant period may contribute to the islet loss and their function.
31
When the islets are transplanted, they need to create new vessels for their normal physiologic function. Recent reports indicate that revascularization process in the transplanted islet can be made from recipient endothelial cell, [35] [36] [37] [38] [39] intraislet endothelial cells of the donor, 31, 40 or chimera from the donor intraislet endothelial cells and recipient. 3, 30 In pig to NHP islet xenotransplantation setting in our study, donor pig endothelial cells were detected in the pig pancreas and isolated islet, but never observed in the graft sites at 20 days after transplantation, and instead, endothelial cells in the islets are only positive for human-specific CD31 antibody, but not for alpha Gal-specific
lectin. This result clearly demonstrated that recipient monkey endothelial cells formed new blood vessels in the transplanted islets. It remains to be determined how monkey endothelial cells within pig islets can communicate beyond species difference.
In conclusion, our results demonstrated that tocilizumab can delay revascularization of the transplanted islet, although this effect had no significant correlation to the overall islet graft survival. Finally, in the pig to NHP islet xenotransplantation model, recipient monkey endothelial forms new blood vessels in and around pig islets. 
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